Companies House · 04750933

CRESCENT PHARMA LIMITED

UK registered company, private limited company, incorporated 1 May 2003.

Active
50
Public contracts
0
Spend payments
Total spend

CRESCENT PHARMA LIMITED is a UK company registered at Companies House under number 04750933. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
04750933
Status
Active
Company type
Private Limited Company
Incorporated
1 May 2003
Country of origin
United Kingdom
Registered office
KEY HOUSE, BASINGSTOKE, HAMPSHIRE, RG21 8SR, ENGLAND
Nature of business (SIC)
21100 - Manufacture of basic pharmaceutical products; 21200 - Manufacture of pharmaceutical preparations
Accounts category
FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to CRESCENT PHARMA LIMITED.

ProcurementBuyerAwardedValue
Generic Anti-Infective DrugsVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14cNHS England
NHS National Proprietary Category Tender - 1 May 2024NHS England
NHS National Generic Pharmaceuticals Wave 15aNHS England
NHS National Generic Pharmaceuticals Wave 15aNHS England
NHS National Generic Pharmaceuticals Wave 15aNHS England
NHS National Generic Pharmaceuticals Wave 15bNHS England
NHS National Generic Pharmaceuticals Interim 2 2020The NHS Commissioning Board (operating under the name of NHS England)
Generic Drugs - Tablets & CapsulesVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales LHB's and Trusts)
Generic Anti-Infective DrugsVelindre NHS Trust, NHS Wales Shared Services Parternship - Procurement Services (On Behalf of All Wales) Health Boards and Trusts
NHS Framework Agreement for Branded Medicines - National TenderNHS England
NHS National Pharmaceuticals Transition 2023_1NHS England
NP30923 Psychiatry and Neurology MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
NP36124 Antibiotic, Antiviral & Genito Urinary MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP36124 Antibiotic, Antiviral & Genito Urinary MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
ENT, Ophthalmology & Skin Medicines/Medical DevicesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Gastrointestinal, Endocrine, Nutrition & Blood MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP30925 Psychiatry and Neurology MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
NP30925 Psychiatry and Neurology MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Generic Drugs - Tablets & CapsulesVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services ( on behalf of All LHB's and Trusts )
Cardiovascular & Respiratory MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Gastro Intestinal, Endocrine, Nutrition & Blood Generic MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Generic MedicineThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Antibiotic, Antiviral & Genito Urinary MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
NP37122 ENT, Ophthalmology & Skin Medicines/Medical DevicesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
NP35923 Cardiovascular & Respiratory MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
NP39823 Gastro Intestinal, Endocrine, Nutrition & Blood MedicineThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Generic Drugs - Topicals & MiscellaneousVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
NHS National Pharmaceuticals - Everolimus and terminated agreement productsThe NHS Commissioning Board (operating under the name of NHS England)
NHS National Pharmaceuticals - Everolimus and terminated agreement productsThe NHS Commissioning Board (operating under the name of NHS England)
NHS National Pharmaceuticals - Everolimus and terminated agreement productsThe NHS Commissioning Board (operating under the name of NHS England)
NHS National Generic Pharmaceuticals Wave 13The NHS Commissioning Board (operating under the name of NHS England)
NHS National Generic Pharmaceuticals Wave 14aNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generic Pharmaceuticals Wave 14bNHS England
NHS National Generics Pharmaceuticals - Supply Chain ResilienceNHS England30 Apr 2026£4.2m
NHS Generic Pharmaceuticals - Wave 15cNHS England13 Jan 2026£403.7m
NHS National Framework for Generics HousekeepingNHS England10 Nov 2025£17.8m
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024NHS England4 Apr 2024£1bn
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2)NHS England4 Mar 2024£1
NHS National Generic Pharmaceuticals Wave 14bATAMIS LTD6 Jul 2023£428.2m
NHS National Generics Pharmaceuticals Transition 2023_1NHS england4 May 2023£57.6m
NHS National Generic Pharmaceuticals Wave 14aNHS England14 Dec 2022£208m
NHS Framework Agreement for Branded medicines - NationalNHS England15 May 2022£526m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m

Supplier identities

How this company appears as a supplier across the data.

FAQs about CRESCENT PHARMA LIMITED

Is CRESCENT PHARMA LIMITED an active company?

CRESCENT PHARMA LIMITED (company number 04750933) is recorded as "Active", incorporated on 1 May 2003.

What does CRESCENT PHARMA LIMITED do?

Its Companies House nature-of-business (SIC) is: 21100 - Manufacture of basic pharmaceutical products; 21200 - Manufacture of pharmaceutical preparations.

Has CRESCENT PHARMA LIMITED won UK public-sector contracts?

Yes — 50 public-sector contract awards are linked to this company in our data.

Where is CRESCENT PHARMA LIMITED based?

Its registered office is KEY HOUSE, BASINGSTOKE, HAMPSHIRE, RG21 8SR, ENGLAND.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable